ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Michael Grever Named DCT Deputy Director; MSK’s Burton Lee New White House Physician

March 31, 1989

Demonstration project to yield useful data, Peter Bach says.

June 3, 2005

Six Panels To Help NCI Identify Progress; NCINews Roundup

January 8, 1993

NCI Programs: New RAID Program Offers NCI Expertise In Drug Development

April 24, 1998

DRCCA Staff Boom To 145, Still Growing, Still Looking for People

November 25, 1983

Centers Form Big Ten Research Consortium with Access to Over 30,000 New Patients a Year

May 31, 2013